These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9081854)

  • 1. End-stage renal disease in NIDDM: a consequence of microangiopathy alone?
    Raine AE; Bilous RW
    Diabetologia; 1996 Dec; 39(12):1673-5. PubMed ID: 9081854
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diabetes mellitus as cause of terminal renal failure. An epidemic of the 21st Century?].
    Carretero-Dios D; Pérez-García R; Rodríguez-Benítez P; Villaverde M; Gómez-Campderá F; Valderrábano F
    Nefrologia; 2001; 21 Suppl 3():83-7. PubMed ID: 11642212
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiologic analysis of the increase in terminal renal insufficiency associated with type 2 diabetes mellitus].
    Lorenzo V; Martín Urcuyo B
    Nefrologia; 2000; 20 Suppl 5():77-81. PubMed ID: 11190112
    [No Abstract]   [Full Text] [Related]  

  • 4. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan.
    Hollenberg NK
    Curr Hypertens Rep; 2001 Jun; 3(3):177. PubMed ID: 11421227
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathogenesis of renal microvascular complications in diabetes mellitus.
    Veldman BA; Vervoort G
    Neth J Med; 2002 Nov; 60(10):390-6. PubMed ID: 12607589
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal disease and hypertension in non-insulin-dependent diabetes mellitus.
    Ismail N; Becker B; Strzelczyk P; Ritz E
    Kidney Int; 1999 Jan; 55(1):1-28. PubMed ID: 9893112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the prevalence of diabetic nephropathy in type 1 and type 2 diabetes.
    Harvey JN
    Curr Opin Nephrol Hypertens; 2003 May; 12(3):317-22. PubMed ID: 12698072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes.
    Cowie CC; Port FK; Wolfe RA; Savage PJ; Moll PP; Hawthorne VM
    N Engl J Med; 1989 Oct; 321(16):1074-9. PubMed ID: 2797067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do we now have a prognostic biomarker for progressive diabetic nephropathy?
    Brosius FC; Saran R
    J Am Soc Nephrol; 2012 Mar; 23(3):376-7. PubMed ID: 22323641
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular disease, chronic kidney disease, and type 2 diabetes mellitus: proceeding with caution at a dangerous intersection.
    Kanda T; Wakino S; Hayashi K; Plutzky J
    J Am Soc Nephrol; 2008 Jan; 19(1):4-7. PubMed ID: 18178795
    [No Abstract]   [Full Text] [Related]  

  • 11. Baseline predictors of end-stage renal disease risk in patients with type 2 diabetes and nephropathy: new lessons from the RENAAL Study.
    Shahinfar S; Dickson T; Zhang Z; Keane WF; Brenner BM;
    Kidney Int Suppl; 2005 Jan; (93):S48-51. PubMed ID: 15663528
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetic nephropathy in type II diabetes.
    Ritz E; Stefanski A
    Am J Kidney Dis; 1996 Feb; 27(2):167-94. PubMed ID: 8659491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Chronic Kidney Disease among Adults with Diabetes, 2015-2020.
    Tuttle KR; Jones CR; Daratha KB; Koyama AK; Nicholas SB; Alicic RZ; Duru OK; Neumiller JJ; Norris KC; Ríos Burrows N; Pavkov ME
    N Engl J Med; 2022 Oct; 387(15):1430-1431. PubMed ID: 36239650
    [No Abstract]   [Full Text] [Related]  

  • 14. Nephropathy in patients with type 2 diabetes mellitus.
    Ritz E; Orth SR
    N Engl J Med; 1999 Oct; 341(15):1127-33. PubMed ID: 10511612
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of end-stage renal failure due to diabetes in the United Kingdom.
    Cameron JS
    J Diabetes Complications; 1992; 6(1):1-6. PubMed ID: 1562752
    [No Abstract]   [Full Text] [Related]  

  • 16. The association between end-stage diabetic nephropathy and methylenetetrahydrofolate reductase genotype with macroangiopathy in type 2 diabetes mellitus.
    Hasegawa G; Obayashi H; Kamiuchi K; Nakai M; Kanatsuna T; Yamaguchi M; Tanaka T; Shigeta H; Fujii M; Yoshikawa T; Nakamura N
    Exp Clin Endocrinol Diabetes; 2003 May; 111(3):132-8. PubMed ID: 12784186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transplantation of the pancreas and kidney in a patient with diabetic microangiopathy].
    Kocandrle V; Bartos V; Vanĕk I; Neuwirtová K; Vondra K
    Cas Lek Cesk; 1984 Feb; 123(5):118-20. PubMed ID: 6365317
    [No Abstract]   [Full Text] [Related]  

  • 18. [The diabetic suffering from severe and progressive microangiopathy: a multidisciplinary commitment].
    Beauregard H; St-Louis G; Daloze P
    Journ Annu Diabetol Hotel Dieu; 1989; ():99-114. PubMed ID: 2668628
    [No Abstract]   [Full Text] [Related]  

  • 19. The rising tide of endstage renal failure from diabetic nephropathy type II--an epidemiological analysis.
    Lippert J; Ritz E; Schwarzbeck A; Schneider P
    Nephrol Dial Transplant; 1995; 10(4):462-7. PubMed ID: 7623988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microalbuminuria in patients with NIDDM: an overview.
    Alzaid AA
    Diabetes Care; 1996 Jan; 19(1):79-89. PubMed ID: 8720542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.